Babu Yarlagadda S

Chief Discovery Officer at BCRX

Sold, on record
$2.8M
Dollars the filings state
Form 4 sales
14
Latest Nov 14, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BCRXBIOCRYST PHARMACEUTICALS INCChief Discovery Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BCRXPlan not stated
    Mar 4, 2014 2014

    Sold 40,642 shares at $12.57 ($511k)

    Babu Yarlagadda S, Senior VP - Drug Discovery

    Sold 16.3% of holdings ($3.1M position)208,195 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BCRXPlan not stated
    Mar 4, 2015 +365 days

    Sold 10,495 shares at $10.50 ($110k)

    Babu Yarlagadda S, Senior VP - Drug Discovery

    Sold 5% of holdings ($2.2M position)198,202 shares leftFiling

  3. 3 Form 4 sale BCRXPlan not stated
    Mar 5, 2015 +1 day

    Sold 37,400 shares at $10.59 ($396k)

    Babu Yarlagadda S, Senior VP - Drug Discovery

    Sold 18.9% of holdings ($2.1M position)160,802 shares leftFiling

  4. 4 Form 4 sale BCRXPlan not stated
    Mar 19, 2015 +14 days

    Sold 12,105 shares at $10.16 ($123k)

    Babu Yarlagadda S, Senior VP - Drug Discovery

    Sold 7.5% of holdings ($1.6M position)148,697 shares left0.3x usual sizeFiling

  5. 5 Form 4 sale BCRXPlan not stated
    Aug 25, 2016 +525 days

    Sold 30,000 shares at $4.06 ($122k)

    Babu Yarlagadda S, Senior VP - Drug Discovery

    Sold 21.2% of holdings ($574k position)111,428 shares left2.5x usual sizeFiling

  6. 6 Form 4 sale BCRXPlan not stated
    Dec 7, 2021 +1930 days

    Sold 30,100 shares at $12.20 ($367k)

    Babu Yarlagadda S, Chief Discovery Officer

    Sold 12.3% of holdings ($3M position)215,056 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale BCRXPlan not stated
    Mar 7, 2022 +90 days

    Sold 20,000 shares at $17.16 ($343k)

    Babu Yarlagadda S, Chief Discovery Officer

    Sold 8% of holdings ($4.3M position)230,056 shares leftFiling

  8. 8 Form 4 sale BCRXPlan not stated
    Nov 14, 2022 +252 days

    Sold 31,515 shares at $13.88 ($437k)

    Babu Yarlagadda S, Chief Discovery Officer

    Sold 9.5% of holdings ($4.6M position)298,541 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Babu Yarlagadda S
Source
Nov 14, 2022Nov 16, 2022BCRXChief Discovery OfficerForm 4 sale31,515$437k9.5%Plan not statedSEC
Mar 7, 2022Mar 9, 2022BCRXChief Discovery OfficerForm 4 sale20,000$343k8.0%Plan not statedSEC
Dec 7, 2021Dec 9, 2021BCRXChief Discovery OfficerForm 4 sale30,100$367k12.3%Plan not statedSEC
Aug 25, 2016Aug 29, 2016BCRXSenior VP - Drug DiscoveryForm 4 sale30,000$122k21.2%Plan not statedSEC
Mar 19, 2015Mar 20, 2015BCRXSenior VP - Drug DiscoveryForm 4 sale12,105$123k7.5%Plan not statedSEC
Mar 5, 2015Mar 6, 2015BCRXSenior VP - Drug DiscoveryForm 4 sale37,400$396k18.9%Plan not statedSEC
Mar 4, 2015Mar 5, 2015BCRXSenior VP - Drug DiscoveryForm 4 sale10,495$110k5.0%Plan not statedSEC
Mar 4, 2014Mar 7, 2014BCRXSenior VP - Drug DiscoveryForm 4 sale40,642$511k16.3%Plan not statedSEC
Mar 2, 2012Mar 5, 2012BCRXVP Drug DiscoveryForm 4 sale837$4k0.7%Plan not statedSEC
Feb 22, 2012Feb 23, 2012BCRXVP Drug DiscoveryForm 4 sale30,912$130k37.0%UnusualSEC
Oct 26, 2009Oct 28, 2009BCRXVP Drug DiscoveryForm 4 sale6,400$69k14.0%Plan not statedSEC
Oct 21, 2009Oct 22, 2009BCRXVP Drug DiscoveryForm 4 sale200$2k0.4%Plan not statedSEC
Oct 20, 2009Oct 21, 2009BCRXVP Drug DiscoveryForm 4 sale3,400$34k6.9%Plan not statedSEC
Sep 23, 2009Sep 24, 2009BCRXVP Drug DiscoveryForm 4 sale20,000$183k28.8%UnusualSEC